VICTORIA, BC – Eupraxia Pharmaceuticals Inc. a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, is pleased… Read More
Decision overlooks compelling evidence that LEQEMBI ® (lecanemab-irmb) meaningfully slows the progression of Alzheimer’s disease and preserves ability to perform activities of daily living for those in the early stages of… Read More
The only FDA‑approved locally applied antibiotic used with scaling and root planing (SRP) marks a quarter‑century of clinical use. LAVAL, QC – Bausch Health Companies Inc., and its dental products… Read More
The team is the first in Canada to receive Horizon Europe funding, leading a project to improve post-hospital care for sepsis. A team led by UBC’s Dr. Matthew Wiens is… Read More
Montreal, QC – OdysseaBio announced an expansion of its strategic scientific communication services to help biotech, pharmaceutical, and life sciences teams translate complex evidence into clear, credible, and decision-ready messaging. The… Read More
